Your browser doesn't support javascript.
loading
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease.
Kemeny, Hanna R; Elsamadicy, Aladine A; Farber, S Harrison; Champion, Cosette D; Lorrey, Selena J; Chongsathidkiet, Pakawat; Woroniecka, Karolina I; Cui, Xiuyu; Shen, Steven H; Rhodin, Kristen E; Tsvankin, Vadim; Everitt, Jeffrey; Sanchez-Perez, Luis; Healy, Patrick; McLendon, Roger E; Codd, Patrick J; Dunn, Ian F; Fecci, Peter E.
Afiliación
  • Kemeny HR; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Elsamadicy AA; Duke University School of Medicine, Durham, North Carolina.
  • Farber SH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Champion CD; Duke University School of Medicine, Durham, North Carolina.
  • Lorrey SJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Chongsathidkiet P; Duke University School of Medicine, Durham, North Carolina.
  • Woroniecka KI; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Cui X; Duke University School of Medicine, Durham, North Carolina.
  • Shen SH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Rhodin KE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Tsvankin V; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Everitt J; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Sanchez-Perez L; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Healy P; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • McLendon RE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Codd PJ; Duke University School of Medicine, Durham, North Carolina.
  • Dunn IF; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Fecci PE; Duke University School of Medicine, Durham, North Carolina.
Clin Cancer Res ; 26(5): 1141-1151, 2020 03 01.
Article en En | MEDLINE | ID: mdl-31744830
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Linfocitos T / Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT) / Antígeno B7-H1 / Inmunoterapia / Anticuerpos Monoclonales Límite: Adolescent / Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Linfocitos T / Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT) / Antígeno B7-H1 / Inmunoterapia / Anticuerpos Monoclonales Límite: Adolescent / Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos